ENTRY       D12464                      Drug
NAME        Dazukibart (USAN)
FORMULA     C6472H9998N1716O2017S46
EXACT_MASS  145501.9677
MOL_WEIGHT  145591.9115
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGYTFS RYWMHWVRQA PGQGLEWMGH IDPSDSYTYY
            NQKFKGRVTI TADESTSTAY MELSSLRSED TAVYYCARWD YGNLLFEYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPEAAGAP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRTSQDIG NYLNWYQQKP GKAFKLLIYS TSRLHSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ GIILPITFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Anti-inflammatory disease
  TYPE      Monoclonal antibody
COMMENT     Treatment of dermatomyositis and systemic lupus erythematosus
TARGET      IFNB [HSA:3456] [KO:K05415]
  PATHWAY   hsa04060(3456)  Cytokine-cytokine receptor interaction
            hsa04620(3456)  Toll-like receptor signaling pathway
            hsa04621(3456)  NOD-like receptor signaling pathway
            hsa04668(3456)  TNF signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interferons
                IFNB
                 D12464  Dazukibart (USAN)
DBLINKS     CAS: 2639474-65-8
///
